Impact of a standardized emergency department asthma care pathway on health services utilization.

IF 2.6 4区 医学 Q2 ALLERGY
Chanel Kwok, Katherine Lajkosz, Carole Madeley, Mona Jabbour, Teresa To, M Diane Lougheed
{"title":"Impact of a standardized emergency department asthma care pathway on health services utilization.","authors":"Chanel Kwok, Katherine Lajkosz, Carole Madeley, Mona Jabbour, Teresa To, M Diane Lougheed","doi":"10.1186/s13223-025-00973-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>An evidence-based standardized ED asthma care pathway (EDACP) was developed and implemented in Ontario, Canada.</p><p><strong>Objective: </strong>To determine the impact of EDACP implementation and access to ED asthma management resources and specialists on return ED visits.</p><p><strong>Methods: </strong>All 173 Ontario hospitals were surveyed regarding their access to community and ED asthma specialists and ED asthma management resources, including EDACP implementation date and status as of August 2017. Survey data were linked to provincial health administrative data to quantify acute health services utilization. A Poisson regression interrupted time series analysis was conducted.</p><p><strong>Results: </strong>Of the 123 hospitals responding to the survey, 44 (35.8%) had approved the EDACP. Data were analyzed for the 5 years preceding (30,028 asthma visits) and 17 months following (7,916 asthma visits) implementation, with a 3-month implementation black-out period. After controlling for auto-regressive factors, EDACP implementation was associated with a 2% reduction in the absolute rate of return ED visits within 72 h (p = 0.0124), and within 7 days (p = 0.0295) at teaching hospitals. The same effect was not seen at community hospitals. Peak expiratory flow testing (available at 77% of sites) and spirometry (available at 45% of sites) were associated with 34% (p = 0.0071) and 23% (p = 0.028) reductions in the odds of return ED visits within 72 h, respectively.</p><p><strong>Conclusion: </strong>The positive results from this large-scale effort to implement an evidence-based knowledge translation initiative in diverse settings, suggests there is merit in continuing to invest time and resources to overcome barriers to adoption and implementation of this EDACP.</p>","PeriodicalId":51302,"journal":{"name":"Allergy Asthma and Clinical Immunology","volume":"21 1","pages":"27"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153106/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy Asthma and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13223-025-00973-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: An evidence-based standardized ED asthma care pathway (EDACP) was developed and implemented in Ontario, Canada.

Objective: To determine the impact of EDACP implementation and access to ED asthma management resources and specialists on return ED visits.

Methods: All 173 Ontario hospitals were surveyed regarding their access to community and ED asthma specialists and ED asthma management resources, including EDACP implementation date and status as of August 2017. Survey data were linked to provincial health administrative data to quantify acute health services utilization. A Poisson regression interrupted time series analysis was conducted.

Results: Of the 123 hospitals responding to the survey, 44 (35.8%) had approved the EDACP. Data were analyzed for the 5 years preceding (30,028 asthma visits) and 17 months following (7,916 asthma visits) implementation, with a 3-month implementation black-out period. After controlling for auto-regressive factors, EDACP implementation was associated with a 2% reduction in the absolute rate of return ED visits within 72 h (p = 0.0124), and within 7 days (p = 0.0295) at teaching hospitals. The same effect was not seen at community hospitals. Peak expiratory flow testing (available at 77% of sites) and spirometry (available at 45% of sites) were associated with 34% (p = 0.0071) and 23% (p = 0.028) reductions in the odds of return ED visits within 72 h, respectively.

Conclusion: The positive results from this large-scale effort to implement an evidence-based knowledge translation initiative in diverse settings, suggests there is merit in continuing to invest time and resources to overcome barriers to adoption and implementation of this EDACP.

标准化急诊科哮喘护理途径对卫生服务利用的影响
背景:加拿大安大略省制定并实施了循证标准化ED哮喘护理途径(EDACP)。目的:确定EDACP实施和获得ED哮喘管理资源和专家对急诊复诊的影响。方法:对安大略省所有173家医院的社区和ED哮喘专家以及ED哮喘管理资源的获取情况进行调查,包括EDACP实施日期和截至2017年8月的状况。调查数据与省级卫生行政数据相关联,以量化急性卫生服务的利用情况。采用泊松回归间断时间序列分析。结果:123家接受调查的医院中,有44家(35.8%)认可了EDACP。数据分析了实施前5年(30,028次哮喘就诊)和实施后17个月(7,916次哮喘就诊)的数据,并进行了3个月的实施中断期。在控制了自回归因素后,EDACP的实施与教学医院72小时内(p = 0.0124)和7天内(p = 0.0295)急诊科绝对复诊率降低2%相关。在社区医院没有看到同样的效果。峰值呼气流量测试(77%的部位可用)和肺活量测定(45%的部位可用)分别与72小时内回访率降低34% (p = 0.0071)和23% (p = 0.028)相关。结论:在不同环境下实施基于证据的知识翻译计划的大规模努力所取得的积极成果表明,继续投入时间和资源来克服采用和实施该EDACP的障碍是值得的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.30
自引率
3.70%
发文量
96
审稿时长
12 weeks
期刊介绍: Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease. By offering a high-visibility forum for new insights and discussions, AACI provides a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, pulmonologists, immunologists and other physicians, healthcare workers, medical students and the public worldwide. AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信